TrialThe international journal of neuropsychopharmacology2009

Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation.

Stephanie S O'Malley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.